当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析 - 现金流量表

国药一致

(000028)

  

流通市值:110.54亿  总市值:128.69亿
流通股本:5.26亿   总股本:6.12亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金58,825,544,288.738,712,113,468.5517,195,099,250.378,140,337,898.35
  收到的税费返还---3,681,379.09
  收到其他与经营活动有关的现金401,500,558.78288,232,007.36153,266,121.8690,056,086.9
  经营活动现金流入小计59,227,044,847.4839,000,345,475.9117,348,365,372.178,834,075,364.34
  购买商品、接受劳务支付的现金54,973,368,037.9537,378,239,733.5918,626,877,356.7670,018,086,293.73
  支付给职工以及为职工支付的现金2,147,815,593.841,493,805,376.15797,322,261.093,223,726,221.65
  支付的各项税费1,238,369,015.06810,086,474.09421,484,768.591,739,622,028.72
  支付其他与经营活动有关的现金1,370,381,188.57836,933,346.32438,014,462.062,214,051,894.97
  经营活动现金流出小计59,729,933,835.4240,519,064,930.1520,283,698,848.577,195,486,439.07
  经营活动产生的现金流量净额-502,888,987.94-1,518,719,454.24-2,935,333,476.41,638,588,925.27
二、投资活动产生的现金流量:
  收回投资收到的现金2,327,084.682,327,084.682,327,084.6821,418,327.56
  取得投资收益收到的现金42,552,714.6934,195,604.59767,164.1999,180,621.55
  处置固定资产、无形资产和其他长期资产收回的现金净额1,146,189.54986,656.94660,709.061,815,131
  收到的其他与投资活动有关的现金---61,800.83
  投资活动现金流入小计46,025,988.9137,509,346.213,754,957.93122,475,880.94
  购建固定资产、无形资产和其他长期资产支付的现金94,436,03659,415,362.0726,970,163.32217,347,683.01
  投资支付的现金---480,000
  取得子公司及其他营业单位支付的现金---7,415,683.18
  支付其他与投资活动有关的现金---157,335.53
  投资活动现金流出小计94,436,03659,415,362.0726,970,163.32225,400,701.72
  投资活动产生的现金流量净额-48,410,047.09-21,906,015.86-23,215,205.39-102,924,820.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金---6,900,000
  其中:子公司吸收少数股东投资收到的现金---6,900,000
  取得借款收到的现金1,509,034,283.691,207,659,924.94749,054,989.351,672,489,123.02
  收到其他与筹资活动有关的现金78,277,979.4965,575,748.1718,103,821.382,391,696.58
  筹资活动现金流入小计1,587,312,263.181,273,235,673.11767,158,810.651,761,780,819.6
  偿还债务支付的现金1,330,428,108.04685,426,579.41152,311,155.111,531,322,545.46
  分配股利、利润或偿付利息支付的现金472,413,158.56446,189,637.8550,600,494.35477,097,339.49
  其中:子公司支付给少数股东的股利、利润21,738,017.0119,481,501.813,313,975.4590,808,325.7
  支付其他与筹资活动有关的现金1,315,223,753.72600,924,052.11231,852,652.731,115,587,136.01
  筹资活动现金流出小计3,118,065,020.321,732,540,269.37434,764,302.193,124,007,020.96
  筹资活动产生的现金流量净额-1,530,752,757.14-459,304,596.26332,394,508.46-1,362,226,201.36
四、汇率变动对现金及现金等价物的影响322,997.25328,320.75-566.2-74,016.45
五、现金及现金等价物净增加额-2,081,728,794.92-1,999,601,745.61-2,626,154,739.53173,363,886.68
  加:期初现金及现金等价物余额7,297,008,417.557,297,008,417.557,297,008,417.557,123,644,530.87
  期末现金及现金等价物余额5,215,279,622.635,297,406,671.944,670,853,678.027,297,008,417.55
补充资料:
  净利润-647,798,030.55-1,128,348,677.76
  资产减值准备--46,072,997.39-290,177,026.92
  固定资产和投资性房地产折旧-82,990,425.25-1,197,864,066.99
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-82,990,425.25--
  无形资产摊销-30,325,955.39-63,316,723.92
  长期待摊费用摊销-62,202,587.17-168,172,386.31
  处置固定资产、无形资产和其他长期资产的损失--533,367.37--7,956,341.59
  固定资产报废损失-296,413.63-1,550,354.65
  公允价值变动损失-7,058,447.12--3,128,755.42
  财务费用-70,181,014.55-194,497,657.99
  投资损失--125,131,974--291,250,467.53
  递延所得税--20,487,159.58--80,654,991.55
  其中:递延所得税资产减少--14,173,889.87--60,019,381.15
    递延所得税负债增加--6,313,269.71--20,635,610.4
  存货的减少--46,799,162.75--721,590,981.71
  经营性应收项目的减少--1,193,847,312.01--1,484,400,432.78
  经营性应付项目的增加--1,375,839,904.3-1,308,619,104.31
  其他--90,298,000.45--213,622,715.06
  不涉及现金收支的投资和筹资活动金额其他项目-394,249,245.08-460,328,993.05
  现金的期末余额-5,297,406,671.94-7,297,008,417.55
  减:现金的期初余额-7,297,008,417.55-7,123,644,530.87
  现金及现金等价物的净增加额--1,999,601,745.61-173,363,886.68
公告日期2026-10-312026-08-292026-04-302026-04-02
审计意见(境内)标准无保留意见
TOP↑